Kameda, R., Nomoto, H., Cho, K. Y., Kawata, S., Omori, K., Takeuchi, J., . . . Miyoshi, H. (2020). Effects of switching from a dipeptidyl peptidase-4 inhibitor to luseogliflozin on nocturnal blood pressure in patients with type 2 diabetes: Protocol for a multicentre, prospective, randomised, open-label, blinded endpoint parallel-group comparison study. BMJ Open.
Citación estilo ChicagoKameda, Reina, et al. "Effects of Switching From a Dipeptidyl Peptidase-4 Inhibitor to Luseogliflozin On Nocturnal Blood Pressure in Patients With Type 2 Diabetes: Protocol for a Multicentre, Prospective, Randomised, Open-label, Blinded Endpoint Parallel-group Comparison Study." BMJ Open 2020.
Cita MLAKameda, Reina, et al. "Effects of Switching From a Dipeptidyl Peptidase-4 Inhibitor to Luseogliflozin On Nocturnal Blood Pressure in Patients With Type 2 Diabetes: Protocol for a Multicentre, Prospective, Randomised, Open-label, Blinded Endpoint Parallel-group Comparison Study." BMJ Open 2020.